Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-5-20
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5957
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
555-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:articleTitle |
[Evaluation of declarations of severe adverse effects from the publication of the decree dated 13 March 1995 about the organisation of pharmacovigilance].
|
pubmed:affiliation |
Unit de Pharmacovigilance, Agence du Médicament, Saint-Denis, France.
|
pubmed:publicationType |
Journal Article
|